BMP2 and breast carcinoma: Our data support the hypothesis (Figure 7) that breast cancer cells with overexpression of BRGs induced by CAF/BMP2 signaling acquire the abilities of homing to, residing in and growing in the bone microenvironment, as well as resistance to multidrug therapies commonly used for breast cancer treatment in the clinic.